MARS Bioimaging Ltd
To provide the worlds best Bio-Diagnostic images for improved healthcare outcomes.
To provide the worlds best Bio-Diagnostic images for improved healthcare outcomes.
Mars Bioimaging Ltd (MBI) was formed in 2007 to commercialise the ground-breaking the MARS imaging system for its applications in medical diagnosis. The MARS imaging system is based on the new generation Medipix chip licensed out of CERN, Switzerland and technology developed by the University of Canterbury (UC) and partners. It has established itself as the world’s leading spectral (multi-energy ‘true colour’) imaging technology. It is the first commercially available spectral, high definition computed tomography (CT) system and has already demonstrated exciting applications.
There is no investment information
No recent news or press coverage available for MARS Bioimaging Ltd.
We care about your data, and we'd love to use cookies make your experience better.
